Commission sets precedent with breast implants
This article was originally published in Clinica
Executive Summary
Draft guidance to ensure uniform risk assessment auditing of breast implant manufacturers has been developed by a project committee within the European Union's Notified Body working group. The draft was prepared at an October 17th meeting in Munich, Germany. It is now being edited and will be submitted to the working group's January meeting.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.